Cytori Therapeutics (CYTX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $2.47 million versus the consensus estimate of $3.1 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
